From today’s PR:
Published (2009-11-09 06:31:06)
From today’s PR: http://finance.yahoo.com/news/Repros-Therapeutics-Inc-bw-341518268.html?x=0&.v=1 [quote]G&A operating and occupancy expenses, which include expenses to operate as a public company, increased 177% or approximately $763,000 to $1.2 million for the three month period ended September 30, 2009 as compared to $432,000 for the same period in the prior year. The increase is primarily due to an increase in legal services of...